ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 233 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,249,903 | +83.8% | 52,188 | +44.5% | 0.06% | +122.2% |
| Q1 2023 | $679,891 | -69.0% | 36,126 | -73.7% | 0.03% | -66.2% |
| Q4 2022 | $2,189,876 | -48.2% | 137,555 | -46.7% | 0.08% | -46.3% |
| Q3 2022 | $4,226,000 | +1610.9% | 258,297 | +1371.3% | 0.15% | +2028.6% |
| Q2 2022 | $247,000 | -60.3% | 17,556 | -34.1% | 0.01% | -70.8% |
| Q4 2021 | $622,000 | +67.2% | 26,637 | +18.8% | 0.02% | +71.4% |
| Q3 2021 | $372,000 | -91.1% | 22,426 | -86.1% | 0.01% | -89.2% |
| Q1 2021 | $4,177,000 | +21.8% | 161,892 | +152.4% | 0.13% | +14.0% |
| Q4 2020 | $3,429,000 | – | 64,134 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
| Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
| ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
| HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
| HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
| SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
| Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
| Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
| GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
| EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |